Creative Medical Technology Holdings, Inc. SEC filings CELZ
Creative Medical Technology Holdings, Inc. has 409 filings in SEC EDGAR's recent list, going back to Sep 13, 2002. Its latest annual report, Form 10-K, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 31, 2026 | — |
| RW | Filing | Jun 30, 2026 | — |
| DRS | Filing | May 28, 2026 | — |
| EFFECT | Filing | Dec 12, 2025 | — |
| CORRESP | Letter to the SEC | Dec 9, 2025 | — |
| EFFECT | Filing | Apr 11, 2025 | — |
| CORRESP | Letter to the SEC | Apr 9, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2025 | — |
| EFFECT | Filing | Nov 19, 2024 | — |
| CORRESP | Letter to the SEC | Nov 15, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2024 | — |
| PRER14A | Prer 14a | Oct 23, 2024 | — |
| EFFECT | Filing | Oct 15, 2024 | — |
| CORRESP | Letter to the SEC | Oct 10, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 10, 2024 | — |
| EFFECT | Filing | May 19, 2022 | — |
| CORRESP | Letter to the SEC | May 17, 2022 | — |
| UPLOAD | Letter from the SEC | May 16, 2022 | — |
| D | Filing | May 5, 2022 | — |
| RW | Filing | May 4, 2022 | — |
| EFFECT | Filing | Dec 2, 2021 | — |
| CERT | Filing | Dec 2, 2021 | — |
| 8-A12B | Filing | Dec 2, 2021 | — |
| CORRESP | Letter to the SEC | Dec 2, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2021 | — |
| CORRESP | Letter to the SEC | Nov 30, 2021 | — |
| CORRESP | Letter to the SEC | Nov 30, 2021 | — |
| CORRESP | Letter to the SEC | Nov 23, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2021 | — |
| D | Filing | Aug 27, 2021 | — |
| NT 10-K | Filing | Mar 30, 2020 | Dec 31, 2019 |
| DEFR14C | Filing | Jan 3, 2020 | — |
| NT 10-Q | Filing | May 15, 2019 | Mar 31, 2019 |
| D | Filing | Sep 28, 2018 | — |
| NT 10-Q | Filing | May 14, 2018 | Mar 31, 2018 |
| D | Filing | Mar 27, 2018 | — |
| D | Filing | Mar 27, 2018 | — |
| D | Filing | Mar 27, 2018 | — |
| D | Filing | Mar 27, 2018 | — |
| D | Filing | Mar 2, 2018 | — |
| D | Filing | Mar 2, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2018 | — |
| CORRESP | Letter to the SEC | Jan 30, 2018 | — |
| PRER14C | Filing | Jan 23, 2018 | — |
| CORRESP | Letter to the SEC | Jan 23, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2018 | — |
| D | Filing | Dec 8, 2017 | — |
| D | Filing | Sep 6, 2017 | — |
| D | Filing | May 11, 2017 | — |
| D | Filing | May 11, 2017 | — |
| D | Filing | May 8, 2017 | — |
| D | Filing | Apr 17, 2017 | — |
| D | Filing | Mar 28, 2017 | — |
| EFFECT | Filing | Mar 3, 2017 | — |
| CT ORDER | Filing | Mar 2, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2017 | — |
| EFFECT | Filing | Dec 12, 2016 | — |
| CORRESP | Letter to the SEC | Dec 8, 2016 | — |
| CORRESP | Letter to the SEC | Nov 21, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2016 | — |
| DRS/A | Filing | Oct 12, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 3, 2016 | — |
| DRSLTR | Filing | Sep 1, 2016 | — |
| DRS/A | Filing | Sep 1, 2016 | — |
| NT 10-Q | 12b-25 | Aug 15, 2016 | Jun 30, 2016 |
| UPLOAD | Letter from the SEC | Jul 1, 2016 | — |
| DRS | Filing | Jun 20, 2016 | — |
| D | Filing | May 23, 2016 | — |
| SC 14F1 | Schedule 14f-1 | May 5, 2016 | — |
| NT 10-K | Form 12b25 notice of late filing | Mar 30, 2016 | Dec 31, 2015 |
| UPLOAD | Letter from the SEC | Aug 21, 2012 | — |
| CORRESP | Letter to the SEC | Aug 17, 2012 | — |
| CORRESP | Letter to the SEC | Aug 16, 2012 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2012 | — |
| 10-12G | Form 10 registration statement | Nov 18, 2008 | — |
| RW | Withdrawal of s-1 | Nov 7, 2008 | — |
| REGDEX | Auto-generated paper document | Aug 11, 2008 | — |
| RW | Filing | Nov 19, 2002 | — |
| SB-2 | Filing | Sep 13, 2002 | — |
Showing 79 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CELZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Phoenix, AZ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1187953
- Former names
- JOLLEY MARKETING INC (until May 13, 2016)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.